Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Roberts

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Elife|December 1, 2022
Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargoSharon Elliot, Paola Catanuto, Simone Pereira-Simon, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Cancer Cell|August 27, 2019
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLSalma Parvin, Ariel Ramirez-Labrada, Shlomzion Aumann, et al.
Nature Communications|December 4, 2025
A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1Ziqi Zhu, Yoon-Mi Chung, Mohammad Alyamani, et al.
Cell Reports|March 27, 2025
Oncogenic properties of wild-type DNA repair gene FANCA in breast cancerLiang Luo, Fenghua Yuan, Anna Palovcak, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
BMJ Global Health|February 18, 2026
The decline of child stunting in 122 countries: a systematic review of child growth studies since the 19th centuryEric B Schneider, Juliana Jaramillo Echeverri, Matthew Purcell, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Elife|December 1, 2022
Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargoSharon Elliot, Paola Catanuto, Simone Pereira-Simon, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Cancer Cell|August 27, 2019
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLSalma Parvin, Ariel Ramirez-Labrada, Shlomzion Aumann, et al.
Nature Communications|December 4, 2025
A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1Ziqi Zhu, Yoon-Mi Chung, Mohammad Alyamani, et al.
Cell Reports|March 27, 2025
Oncogenic properties of wild-type DNA repair gene FANCA in breast cancerLiang Luo, Fenghua Yuan, Anna Palovcak, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
BMJ Global Health|February 18, 2026
The decline of child stunting in 122 countries: a systematic review of child growth studies since the 19th centuryEric B Schneider, Juliana Jaramillo Echeverri, Matthew Purcell, et al.
Pageof 4